The value and limitations of new oral anticoagulant plasma level assessments

The class of new oral anticoagulants (NOACs) has been developed to provide reliable oral anticoagulation without the need for therapeutic drug monitoring. Based on phase I and II trials and pharmacokinetic and pharmacodynamic modeling, fixed drug doses have been selected for large phase III clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Van der Linden, Lorenz, Hias, Julie, Vanassche, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Supplement Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850711/
https://www.ncbi.nlm.nih.gov/pubmed/35185407
http://dx.doi.org/10.1093/eurheartj/suab153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850711/
https://www.ncbi.nlm.nih.gov/pubmed/35185407
http://dx.doi.org/10.1093/eurheartj/suab153

Ejemplares similares